Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era
Cancers · 22.04.2024 · 16 (8) · 1594
DOI: 10.3390/cancers16081594 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.04.2024. Verfasst von Ari D Kappel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High-grade gliomas (HGGs) have a poor prognosis and are difficult to treat. This review examines the evolving landscape of endovascular therapies for HGGs. Recent advances in endovascular catheter technology and delivery methods allow for super-selective intra-arterial cerebral infusion (SSIACI) with increasing precision. This treatment modality may offer the ability to deliver anti-tumoral therapies directly to tumor regions while minimizing systemic toxicity. However, challenges persist, including blood–brain barrier (BBB) penetration, hemodynamic complexities, and drug–tumor residence time. Innovative adjunct techniques, such as focused ultrasound (FUS) and hyperosmotic disruption, may facilitate BBB disruption and enhance drug penetration. However, hemodynamic factors that limit drug residence time remain a limitation. Expanding therapeutic options beyond chemotherapy, including radiotherapy and immunobiologics, may motivate future investigations. While preclinical and clinical studies demonstrate moderate efficacy, larger randomized trials are needed to validate the clinical benefits. Additionally, future directions may involve endovascular sampling for peri-tumoral surveillance; changes in drug formulations to prolong residence time; and the exploration of non-pharmaceutical therapies, like radioembolization and photodynamic therapy. Endovascular strategies hold immense potential in reshaping HGG treatment paradigms, offering targeted and minimally invasive approaches. However, overcoming technical challenges and validating clinical efficacy remain paramount for translating these advancements into clinical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard Medical School, Boston, MA 02115, USA.
- Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
- Neurosurgery Section, School of Medicine University of Puerto Rico, Medical Sciences Campus, San Juan P.O. Box 365067, Puerto Rico.
- Department of Neurosurgery, Rostock University Hospital, 18057 Rostock, Germany.
- Department of Neurosurgery, Boston Children's Hospital, Boston, MA 02115, USA.
ORCID-Profile: Ari D Kappel, Rodolfo E Alcedo Guardia, Florian A Gessler, Rose Du, Alfred P See, Pier Paolo Peruzzi, Joshua D Bernstock
Zitieren
APA
Kappel, A. D., Jha, R., Guggilapu, S., Smith, W. J., Feroze, A. H., Dmytriw, A. A., Vicenty-Padilla, J., Alcedo Guardia, R. E., Gessler, F. A., Patel, N. J., Du, R., See, A. P., Peruzzi, P. P., Aziz-Sultan, M. A., & Bernstock, J. D. (2024). Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era. Cancers, 16(8), 1594. https://doi.org/10.3390/cancers16081594
Vancouver
Kappel AD, Jha R, Guggilapu S, Smith WJ, Feroze AH, Dmytriw AA, et al. Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era. Cancers. 2024;16(8):1594. doi:10.3390/cancers16081594
BibTeX
@article{Kappel2024,
author = {Kappel, Ari D and Jha, Rohan and Guggilapu, Saibaba and Smith, William J and Feroze, Abdullah H and Dmytriw, Adam A and Vicenty-Padilla, Juan and Alcedo Guardia, Rodolfo E and Gessler, Florian A and Patel, Nirav J and Du, Rose and See, Alfred P and Peruzzi, Pier Paolo and Aziz-Sultan, Mohammad A and Bernstock, Joshua D},
title = {Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era},
journal = {Cancers},
year = {2024},
volume = {16},
number = {8},
pages = {1594},
doi = {10.3390/cancers16081594}
}
EUVIMED